NTUitive_WhyStartUp___1400x365___1400x365.jpg

Osteopore International Pte Ltd

Biomedical & Healthcare

Osteopore1.jpg
Osteopore2.jpg
Osteopore3.PNG
Osteopore1.jpg
Osteopore2.jpg
Osteopore3.PNG

Company Overview

Osteopore International Pte Ltd, a Singapore based corporation, is the global 1st to commercially introduce a biomimetic 3-D printed bioresorbable biostructure for natural tissue regeneration. With this patented technology and US FDA 510K status, Osteopore International is a leader in designing, developing and marketing Regenerative Medical Devices for neurosurgical, craniomaxillofacial, plastics reconstruction and aesthetic, orthopaedic and spinal surgical applications.

Osteopore International’s proprietary technologies produce biostructures that are synthetic tissue engineered products for the restoration of the human skeleton. Industry analyst believe that Osteopore International's core technology provides multiple opportunities for growth through developing surgical implants and for pursuing rapid regulatory approval for its products to initiate near term revenue opportunities. A 10-year retrospective clinical study for the neurosurgical and oculoplastcs application demonstrated successful regeneration of patients’ own bone cells. The research team is developing the technology further to enable the scaffold to be implanted in other parts of the body.

Osteopore has received the 2016 Frost & Sullivan Singapore 3D Scaffolds Entrepreneurial Company of the Year Award.

Features

- Received Frost & Sullivan Award for 3D Scaffolds Entrepreneurial Company of the Year Award, 2016.


- Currently developing technology further to enable scaffold for implant in other parts of the human body.